Cingulate Inc. Warrants
Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials. It also develops CTx-2103 (buspirone) that is in a formulation stage for th… Read more
Market Cap & Net Worth: Cingulate Inc. Warrants (CINGW)
Cingulate Inc. Warrants (NASDAQ:CINGW) has a market capitalization of $463.62 ($463.62) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #38303 globally and #12465 in its home market, demonstrating a 35.23% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cingulate Inc. Warrants's stock price $0.05 by its total outstanding shares 9291 (9.29K).
Cingulate Inc. Warrants Market Cap History: 2021 to 2026
Cingulate Inc. Warrants's market capitalization history from 2021 to 2026. Data shows change from $6.60K to $463.62 (-50.41% CAGR).
Cingulate Inc. Warrants Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cingulate Inc. Warrants's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of CINGW by Market Capitalization
Companies near Cingulate Inc. Warrants in the global market cap rankings as of March 18, 2026.
Key companies related to Cingulate Inc. Warrants by market ranking:
- SANDVIK - Dusseldorf Stock Exchang (DU:SVKB): Ranked #38294 globally with a market cap of $331.84K USD ( €323.28K EUR).
- KAO (KAO.SG) (STU:KAO): Ranked #38295 globally with a market cap of $331.05K USD ( €322.51K EUR).
- Lanbay Inc (PINK:LNBY): Ranked #38304 globally with a market cap of $330.16K USD.
- Syros Pharmaceuticals Inc (NASDAQ:SYRS): Ranked #38305 globally with a market cap of $329.84K USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #38294 | SANDVIK - Dusseldorf Stock Exchang | DU:SVKB | $331.84K | €34.90 |
| #38295 | KAO (KAO.SG) | STU:KAO | $331.05K | €33.17 |
| #38304 | Lanbay Inc | PINK:LNBY | $330.16K | $0.54 |
| #38305 | Syros Pharmaceuticals Inc | NASDAQ:SYRS | $329.84K | $0.02 |
Cingulate Inc. Warrants Historical Marketcap From 2021 to 2026
Between 2021 and today, Cingulate Inc. Warrants's market cap moved from $6.60K to $ 463.62, with a yearly change of -50.41%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $463.62 | -8.78% |
| 2025 | $508.22 | +6.21% |
| 2024 | $478.49 | +71.67% |
| 2023 | $278.73 | -85.72% |
| 2022 | $1.95K | -70.41% |
| 2021 | $6.60K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Cingulate Inc. Warrants was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $463.62 USD |
| MoneyControl | $463.62 USD |
| MarketWatch | $463.62 USD |
| marketcap.company | $463.62 USD |
| Reuters | $463.62 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.